Background: HIV-1 assembles at the plasma membrane of host cells as immature, non-infectious particles. Processing of Gag and Gag-Pol polyproteins catalyzed by the viral protease (PR) activates the viral enzymes and results in dramatic structural rearrangements within the particle. Formation of the mature HIV-1 core is a prerequisite for infectivity; processing and morphological maturation thus represent important targets for antiretroviral therapy. When and how fast the maturation event occurs are two basic questions that surprisingly still remain unanswered. Whereas the architecture of start and end point – the immature and mature virion – is well characterized, structural intermediates delineating the pathway of morphological maturation are missing. Biochemical ensemble measurements and structural analyses are hampered by the fact that HIV-1 release and maturation in tissue culture occur asynchronously between individual cells and between individual particles released from the same cell. We have established a method to synchronize HIV-1 proteolytic maturation in vitro with the aim to allow a more detailed analysis of the maturation process. Methodology: Immature virions were prepared from cells treated with high concentrations of PR inhibitor and an inhibitor wash-out strategy was developed to induce proteolytic maturation of polyproteins within the assembled particles. Using this approach, we followed the production of mature Gag and Gag-Pol processing products over time. These data were correlated with analysis of viral infectivity, reverse transcriptase (RT) activity and virion morphology. Results: Preparation of immature virions followed by inhibitor wash-out resulted in complete processing of Gag into its mature subunits with a t1/2 of ~4 h under optimized conditions, suggesting that factors other than PR activity were limiting in this setup. Infectivity of ‘in vitro matured’ virions was detectably higher than that of the corresponding immature particles; recovery of infectivity was only partial, however, yielding low titers compared to mature virus prepared in the absence of inhibitor. Incomplete recovery of infectivity in spite of complete Gag maturation correlated with pronounced defects in Gag-Pol maturation and RT enzymatic activity. Conclusions: We conclude that the complex process of HIV-1 maturation, occurring at high protein concentrations in a confined space, cannot be easily reconstituted within an already assembled immature virion. We therefore assume that tight temporal control between immature particle assembly and proteolytic processing is required to allow for correct polyprotein cleavage and arrangement of mature protein subunits. Further studies are directed towards elucidating this complex relationship.